What's going on in today's session: S&P500 most active stocks
By Mill Chart
Last update: May 2, 2024
Stay informed about the most active stocks in the S&P500 index on Thursday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Most active stocks
| Ticker | Change | Comment |
|---|---|---|
| TSLA | 0.03% | Today, the market has shown strong interest in TESLA INC (NASDAQ:TSLA) as 66.44M shares have already been traded. Investors witnessed a substantial increase in share prices, with a gain of 0.03%. |
| PFE | 1.87% | So far, a total of 40.29M shares of PFIZER INC (NYSE:PFE) have been traded in today's session. The share price increased by 1.87%. A press release (Pfizer Reports First-Quarter 2024 Results) was released yesterday. |
| AAPL | 1.92% | Today, the market has shown strong interest in APPLE INC (NASDAQ:AAPL) as 36.7M shares have already been traded. The latest market activity led to a price increase of 1.92%, signaling a positive trend in the market. yesterday the company released their earnings. |
| AMD | 0.69% | So far, a total of 36.3M shares of ADVANCED MICRO DEVICES (NASDAQ:AMD) have been traded in today's session. The market is experiencing a notable price surge, with a rise of 0.69% across the board. A press release (AMD is Down 35%. Now is the Time to Buy the Dip) was released yesterday. |
| AMZN | 3.27% | Investors have been actively buying and selling shares of AMAZON.COM INC (NASDAQ:AMZN) in today's session, resulting in a trading volume of 31.72M shares. The share price increased by 3.27%. Two days ago the company had a press release: Amazon.com Announces First Quarter Results. |
| F | 1.73% | So far 26.05M shares of FORD MOTOR CO (NYSE:F) have traded in today's session. Investors witnessed a substantial increase in share prices, with a gain of 1.73%. |
| INTC | -0.28% | So far, a total of 25.98M shares of INTEL CORP (NASDAQ:INTC) have been traded in today's session. Leading to a price decrease of 0.28%. Yesterday the company had a press release: More than 500 AI Models Run Optimized on Intel Core Ultra Processors. |
| NVDA | 2.79% | 25.25M shares of NVIDIA CORP (NASDAQ:NVDA) exchanged hands today. Shares are rising by 2.79%. |
| CVS | -2.82% | The trading volume for CVS HEALTH CORP (NYSE:CVS) has been quite high, with 24.79M shares exchanged. Shares are falling by 2.82%. |
| PARA | 9.47% | 20.93M shares of PARAMOUNT GLOBAL-CLASS B (NASDAQ:PARA) exchanged hands today. The latest market activity led to a price increase of 9.47%, signaling a positive trend in the market. |
Our most active stocks screener will show you the full list.
PFIZER INC
NYSE:PFE (5/31/2024, 7:04:00 PM)
After market: 28.74 +0.08 (+0.28%)28.66
+0.46 (+1.63%)
PFE News
10 hours ago - InvestorPlace3 Discounted Stocks Poised for a Major UpswingExplore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon.
11 hours ago - InvestorPlaceBlue-Chip Blunders: 7 Stocks to Sell as Management Missteps MountSometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.
a day ago - The Motley Fool3 Stocks to Buy for Huge IncomeAll 3 of these stocks have a yield above 5%.
a day ago - Pfizer Inc.Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
a day ago - Takeda Pharmaceutical Company LimitedTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2 days ago - The Motley FoolIs Pfizer the Best Dividend Stock for You?Short-term expectation worries have elevated Pfizer's dividend yield.
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
2 days ago - Investor's Business DailyModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSKModerna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
2 days ago - Zacks Investment ResearchPfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2 days ago - CNBCFDA approves Moderna's RSV vaccine for seniors, the company's second-ever productThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
2 days ago - BusinessInsiderQUALCOMM To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
2 days ago - QuartzPfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trialPfizer Chief Oncology Officer Chris Boshoff said the drug could reach $1 billion in annual sales by 2030
